Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating Severe Brain-injured Patients With Apomorphine: a Behavioral and Neuroimaging Study

NCT03623828 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT03623828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03623828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating Severe Brain-injured Patients With Apomorphine: a Behavioral and Neuroimaging Study
Lead sponsor
University of Liege
Phase
Phase 2
Overall status
Unknown status
Start date
October 3, 2018
Completion date
November 13, 2022
Enrollment
8 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

disorder of consciousness